Sign inGet started

Grissinger Michael

Insider CIK 1757601 · LPCN Director · AKTX Director · TORC Director · APRE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LPCN Lipocine Inc. A Award deriv2026-08-032026-08-072,000$2.11 $4.2K2,000SEC↗
LPCN Lipocine Inc. A Award deriv2026-08-032026-08-072,000$2.11 $4.2K2,000SEC↗
ACET Adicet Bio, Inc. A Award deriv2026-06-212026-06-234,200— $04,200SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2026-06-162026-06-1712,555— $012,555SEC↗
APRE Aprea Therapeutics, Inc. A Award2026-06-162026-06-173,135— $06,024SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2025-06-052025-06-094,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2025-06-052025-06-091,045— $02,889SEC↗
ACET Adicet Bio, Inc. A Award deriv2025-04-172025-04-2170,200— $070,200SEC↗
AKTX Akari Therapeutics Plc A Award deriv2024-06-282024-07-025,000,000— $05,000,000SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2024-06-202024-06-214,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2024-06-202024-06-211,045— $01,844SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2023-08-232023-08-242,000— $02,000SEC↗
APRE Aprea Therapeutics, Inc. A Award2023-08-232023-08-24500— $0799SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2022-07-282022-08-0129,575— $029,575SEC↗
APRE Aprea Therapeutics, Inc. A Award2022-07-282022-08-015,995— $05,995SEC↗
TORC resTORbio, Inc. A Award deriv2020-06-032020-06-0514,414— $014,414SEC↗
TORC resTORbio, Inc. A Award deriv2019-05-082019-05-0914,414— $014,414SEC↗
TORC resTORbio, Inc. A Award deriv2018-11-052018-11-0628,828— $028,828SEC↗